A case of very rare co-occurrence of POEMS syndrome and JAK2 V617F positive MPN

被引:0
|
作者
Alaikov, Tzvetan [1 ]
Angelova, Svetlana [2 ]
Hristova, Julieta [3 ]
Ivanova, Milena [4 ]
Shivarov, Velizar [1 ,5 ]
机构
[1] Sofiamed Univ Hosp, Dept Clin Hematol, Block 2,10 Dimitar Mollov Str, Sofia 1750, Bulgaria
[2] Natl Hematol Hosp, Lab Cytogenet & Mol Biol, Sofia, Bulgaria
[3] Med Univ Sofia, Alexandrovska Univ Hosp, Lab Clin Chem, Sofia, Bulgaria
[4] Med Univ Sofia, Alexandrovska Univ Hosp, Lab Clin Immunol, Sofia, Bulgaria
[5] Sofiamed Univ Hosp, Lab Clin Immunol, Sofia, Bulgaria
关键词
ENDOTHELIAL GROWTH-FACTOR; WALDENSTROMS MACROGLOBULINEMIA;
D O I
10.1007/s12308-018-0317-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:23 / 26
页数:4
相关论文
共 50 条
  • [1] A case of very rare co-occurrence of POEMS syndrome and JAK2 V617F positive MPN
    Tzvetan Alaikov
    Svetlana Angelova
    Julieta Hristova
    Milena Ivanova
    Velizar Shivarov
    Journal of Hematopathology, 2018, 11 : 23 - 26
  • [2] Occurrence of the JAK2 V617F mutation in the Budd-Chiari syndrome
    Colaizzo, Donatella
    Amitrano, Lucio
    Tiscia, Giovanni L.
    Iannaccone, Luigi
    Gallone, Anna
    Grandone, Elvira
    Guardascione, Maria A.
    Margaglione, Maurizio
    BLOOD COAGULATION & FIBRINOLYSIS, 2008, 19 (05) : 459 - 462
  • [3] A rare case of JAK2 V617F positive polycythemia vera in a child with neurofibromatosis type 1
    Berman, Jason N.
    Greer, Wencla L.
    Loh, Mignon
    Riddell, Christie
    Morash, Barbara
    Dumas, Nadine
    Fernandez, Conrad V.
    Ludman, Mark
    BLOOD, 2007, 110 (11) : 239B - 239B
  • [4] The prevalence of JAK2 V617F mutation in myelodysplastic syndrome
    Antolic, M. Radic
    Zadro, R.
    Roncevic, P.
    Kinda, S. Basic
    Labar, B.
    BLOOD REVIEWS, 2007, 21 : S126 - S126
  • [5] The V617F mutation of JAK2 is very uncommon in patients with thrombosis
    Remacha, Angel F.
    Estivill, Camino
    Pilar Sarda, M.
    Mateo, Jose
    Carles Souto, Joan
    Canals, Carme
    Nomdedeu, Josep
    Fontcuberta, Jordi
    HAEMATOLOGICA, 2007, 92 (02) : 285 - 286
  • [6] Angiogenesis in JAK2 V617F positive myeloproliferative neoplasms and ruxolitinib decrease VEGF, HIF-1 enesis in JAK2 V617F positive cells
    Cheng, Zhiyong
    Fu, Jianzhu
    Liu, Guimin
    Zhang, Lijun
    Xu, Qian
    Wang, Su-yun
    LEUKEMIA & LYMPHOMA, 2018, 59 (01) : 196 - 203
  • [7] JAK2, the JAK2 V617F mutant and cytokine receptors
    Staerk, J.
    Kallin, A.
    Royer, Y.
    Diaconu, C. C.
    Dusa, A.
    Demoulin, J.-B.
    Vainchenker, W.
    Constantinescu, S. N.
    PATHOLOGIE BIOLOGIE, 2007, 55 (02): : 88 - 91
  • [8] Chronic myeloid leukemia patient with co-occurrence of BCR-ABL junction and JAK2 V617F mutation
    Weiyi Xu
    Baode Chen
    Xiangmin Tong
    International Journal of Hematology, 2014, 99 : 87 - 90
  • [9] Neutrophilia and the JAK2 V617F Mutation
    Langabeer, Stephen E.
    Haslam, Karl
    PATHOLOGY & ONCOLOGY RESEARCH, 2019, 25 (01) : 437 - 438
  • [10] Chronic myeloid leukemia patient with co-occurrence of BCR-ABL junction and JAK2 V617F mutation
    Xu, Weiyi
    Chen, Baode
    Tong, Xiangmin
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2014, 99 (01) : 87 - 90